Related Experiment Videos
Regulation of the TAK1 signaling pathway by protein phosphatase 2C
M Hanada1, J Ninomiya-Tsuji, K Komaki
1Department of Biochemistry, Institute of Development, Aging, and Cancer, Tohoku University, 4-1 Seiryomachi, Aoba-ku, Sendai 980-8575, Japan.
Abstract:
Protein phosphatase 2C (PP2C) is implicated in the negative regulation of stress-activated protein kinase cascades in yeast and mammalian cells. In this study, we determined the role of PP2Cbeta-1, a major isoform of mammalian PP2C, in the TAK1 signaling pathway, a stress-activated protein kinase cascade that is activated by interleukin-1, transforming growth factor-beta, or stress. Ectopic expression of PP2Cbeta-1 inhibited the TAK1-mediated mitogen-activated protein kinase kinase 4-c-Jun amino-terminal kinase and mitogen-activated protein kinase kinase 6-p38 signaling pathways. In vitro, PP2Cbeta-1 dephosphorylated and inactivated TAK1. Coimmunoprecipitation experiments indicated that PP2Cbeta-1 associates with the central region of TAK1. A phosphatase-negative mutant of PP2Cbeta-1, PP2Cbeta-1 (R/G), acted as a dominant negative mutant, inhibiting dephosphorylation of TAK1 by wild-type PP2Cbeta-1 in vitro. In addition, ectopic expression of PP2Cbeta-1(R/G) enhanced interleukin-1-induced activation of an AP-1 reporter gene. Collectively, these results indicate that PP2Cbeta negatively regulates the TAK1 signaling pathway by direct dephosphorylation of TAK1.
Insights
Protein Phosphatase 2C (PP2C) isoform beta-1 directly dephosphorylates and inactivates TAK1, a key kinase in stress signaling. This reveals PP2Cbeta-1 as a negative regulator of the TAK1 pathway.
Area of Science:
- Cellular signaling pathways
- Kinase regulation
- Protein dephosphorylation
Background:
- Protein Phosphatase 2C (PP2C) regulates stress-activated protein kinase cascades.
- The TAK1 signaling pathway is activated by inflammatory cytokines and cellular stress.
- Understanding PP2C's role in TAK1 signaling is crucial for cellular stress response.
Purpose of the Study:
- To investigate the role of PP2Cbeta-1, a mammalian PP2C isoform, in the TAK1 signaling pathway.
- To elucidate the mechanism by which PP2Cbeta-1 regulates TAK1 activity.
- To determine if PP2Cbeta-1 directly interacts with and modifies TAK1.
Main Methods:
- Ectopic expression of PP2Cbeta-1 and its mutant in mammalian cells.
- In vitro kinase assays to assess TAK1 activity.
- Co-immunoprecipitation to study protein-protein interactions.
- AP-1 reporter gene assays to measure downstream signaling.
Main Results:
- PP2Cbeta-1 inhibited TAK1-mediated activation of MAPK signaling pathways (MKK4-JNK and MKK6-p38).
- PP2Cbeta-1 directly dephosphorylated and inactivated TAK1 in vitro.
- PP2Cbeta-1 physically associated with the central region of TAK1.
- A dominant-negative mutant of PP2Cbeta-1 blocked TAK1 dephosphorylation and enhanced IL-1-induced AP-1 activation.
Conclusions:
- PP2Cbeta-1 negatively regulates the TAK1 signaling pathway.
- The mechanism involves direct dephosphorylation and inactivation of TAK1 by PP2Cbeta-1.
- PP2Cbeta-1 acts as a critical negative feedback regulator in stress-activated signaling cascades.